Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 429-600-4 | CAS number: 1026988-42-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 417
- GLP compliance:
- yes
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- - Name of test material (as cited in study report): 14C-Basisch Gelb 8511
- Physical state: solid
- Lot/batch No.: 718-1003
- Radiochemical purity (if radiolabelling): > 95%
- Storage condition of test material: at 4°C in the dark
- Radiolabelling:
- yes
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Boehringer Ingelheim Pharma KG
- Age at study initiation: about 8 weeks at application
- Weight at study initiation: ca. 261- 299 g
- Housing: During acclimatization and prior to the experiment in type III Macrolon cages; during experiments individually in all-glass metabolism
cages; type Metabowl (Jencons, Leighton Buzzard, UK) which were labelled with the project number and the animal number.
- Diet ad libitum
- Water ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): 30-70%
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- other: acetate buffer
- Duration of exposure:
- 8 hours
- Doses:
- - Nominal doses: 0.080; 0.016; 0.0032 mg/cm² corresponding to 0.80, 0.16 and 0.032 mg/animal and about 3.8, 0.7 and 0.2 mg/kg body weight
- Dose volume: 10 µl/cm²
- Rationale for dose selection: The dermal application was selected in order to simulate potential exposure scenarios. According to the relevant guidelines, experiments shall be performed using doses expected in practice. Dose levels were calculated with the following assumptions: The concentration of Basisch Gelb 8511 in paper is about 0.2 %. With paper of 80 g/m², this corresponds to 160 mg Basisch Gelb 8511/m². Assuming that the flat of both hands is in contact with paper (ca. 400 cm²) and that the dye in paper is completely available for penetration, exposure can be calculated to be 6.4 mg/400 cm², corresponding to 0.016 mg/cm² (= intermediate dose level). Using a factor of 5 upwards and downwards, 0.08 and 0.0032 mg/cm² were selected as additional dose levels. - No. of animals per group:
- 4
- Control animals:
- no
- Details on study design:
- In this set of experiments, animals were dosed and then placed in metabolism cages in order to collect excreta up to 72 hours. After 8 hours of exposure, the protective cover was removed and the exposed skin was washed with a mild soap solution. After 72 hours, animals were sacrificed and the following specimens/tissues were checked for remaining radioactivity: excreta, bloodcells, plasma, liver, kidneys, carcass, skin (treated (= application site) and non-treated areas (surrounding skin)). For balance estimates the cage wash and skin wash as well as the protective cover (including the silicone ring) were also checked for radioactivity.
Results and discussion
Percutaneous absorptionopen allclose all
- Dose:
- 0.080 mg/cm²
- Parameter:
- percentage
- Absorption:
- 0.4 %
- Remarks on result:
- other: 72 hours
- Remarks:
- After 8 hours of exposure, the protective cover was removed and the exposed skin was washed with a mild soap solution.
- Dose:
- 0.016 mg/cm²
- Parameter:
- percentage
- Absorption:
- 0.8 %
- Remarks on result:
- other: 72 hours
- Remarks:
- After 8 hours of exposure, the protective cover was removed and the exposed skin was washed with a mild soap solution.
- Dose:
- 0.0032 mg/cm²
- Parameter:
- percentage
- Absorption:
- 1.2 %
- Remarks on result:
- other: 72 hours
- Remarks:
- After 8 hours of exposure, the protective cover was removed and the exposed skin was washed with a mild soap solution.
Any other information on results incl. tables
- High dose:
Following a single dermal administration of14C-BASISCH GELB 8511 at a nominal dose level of 0.080 mg/cm² (0.80 mg/animal or about 3.8 mg/kg body weight), the recovery of radioactivity was between 91.83% and 95.11% of the applied radioactivity. The largest portion of radioactivity was recovered from the skin wash (85.83% of dose). In the dressing, 0.88% of the applied radioactivity was found. The application site contained 4.00% of the applied radioactivity. The penetration of radioactivity into the skin adjacent to the application site was 0.42% of the applied radioactivity. The amount of radioactivity absorbed (including excreta, cage wash, tissues/organs and carcass) was 0.39%. The absorbed radioactivity was excreted mainly via the feces. Due to the very limited skin penetration, concentrations of radioactivity in organs and tissues analyzed were very low with the remaining carcass showing the highest values being about 0.005 µg Eq/g tissue.
- Intermediate dose:
Following a single dermal administration of14C-BASISCH GELB 8511 at a nominal dose level of 0.016 mg/cm² (0.16 mg/animal or about 0.7 mg/kg body weight), the recovery of radioactivity was between 92.30% and 96.12% of the applied radioactivity. The largest portion of radioactivity was recovered from the skin wash (77.69% of dose). In the dressing, 2.58% of the applied radioactivity was found. The application site contained 9.20% of the applied radioactivity. The penetration of radioactivity into the skin adjacent to the application site was 0.65% of the applied radioactivity. The amount of radioactivity absorbed (including excreta, cage wash, tissues/organs and carcass) was 0.85%. The absorbed radioactivity was excreted mainly via the feces. Due to the very limited skin penetration, concentrations of radioactivity in organs and tissues analyzed were very low with the kidneys and the remaining carcass showing the highest values being about 0.002 µg Eq/g tissue.
- Low dose:
Following a single dermal administration of14C-BASISCH GELB 8511 at a nominal dose level of 0.0032 mg/cm² (0.032 mg/animal or about 0.2 mg/kg body weight), the recovery of radioactivity was between 90.34% and 95.21% of the applied radioactivity. The largest portion of radioactivity was recovered from the skin wash (76.85% of dose). In the dressing, 1.49% of the applied radioactivity was found. The application site contained 12.48% of the applied radioactivity. The penetration of radioactivity into the skin adjacent to the application site was 0.51% of the applied radioactivity. The amount of radioactivity absorbed (including excreta, cage wash, tissues/organs and carcass) was 1.25%. The absorbed radioactivity was excreted mainly via the feces. Due to the very limited skin penetration, concentrations of radioactivity in organs and tissues analyzed were very low with kidneys and the remaining carcass showing the highest values being about 0.001 µg Eq/g tissue.
A comparison of the penetration at the different dose levels shows, that the percentage of radioactivity absorbed decreased with increasing dose indicating saturation of skin penetration with increasing dose. An increase in dose by a factor of 5 resulted in 30-50% decrease in the percentage of radioactivity absorbed.
Applicant's summary and conclusion
- Conclusions:
- Following single dermal administration of 14C-BASISCH GELB 8511 diluted in an acetate buffer, there was very limited systemic absorption amounting to 1.25 % of the dose applied at maximum. With increasing dose the percentage of radioactivity absorbed decreased indicating saturation of skin penetration with increasing dose. Due to the limited skin penetration, concentrations of radioactivity in organs and tissues analyzed were very low with kidneys and the remaining carcass showing the highest values.
- Executive summary:
The study was conducted according to OECD guideline 417 in compliance with GLP.
Mean recoveries of radioactivity from all dose groups were in the range of 90.34 - 96.12% of the total radioactivity administered. The largest portion of radioactivity was recovered from the skin wash (>76 %). Whereas 1.25 % of the applied radioactivity was absorbed at maximum at the low dose level, relative absorption decreased to about 0.85% at the intermediate dose level and to about 0.39 % at the high dose level. These.results clearly indicated saturation of penetration with increasing dose.
Dose level (mg/cm²)
% of radioactivity absorbed
0.080
0.39
0.016
0.85
0.0032
1.25
The radioactivity absorbed was excreted mainly via the feces. Due to the very limited skin penetration, concentrations of radioactivity in organs and tissues analyzed were very low.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.